ONCOCROSS

  • Company

    • Mission

    • About Us

    • History

    • Leadership

    • Scientific Advisory Board

  • Business Areas

    • Neo Omics

    • DBB

    • Early Cancer Detection & Monitoring

    • Collaboration

  • Technology Platform

    • RAPTOR AI® VERSION 2.0

    • ONCOfind AI ®

  • Pipeline

  • News/IR

    • Notice

    • Press Releases

    • IR Materials

    • Knowledge Hub

    • Latest Cancer Information

    • Disclosure Information

    • Stock Information

  • OncoMaster

CONTACT US
  • KR
  • EN
  • Company

    • Mission

    • About Us

    • History

    • Leadership

    • Scientific Advisory Board

  • Business Areas

    • Neo Omics

    • DBB

    • Early Cancer Detection & Monitoring

    • Collaboration

  • Technology Platform

    • RAPTOR AI® VERSION 2.0

    • ONCOfind AI ®

  • Pipeline

  • News/IR

    • Notice

    • Press Releases

    • IR Materials

    • Knowledge Hub

    • Latest Cancer Information

    • Disclosure Information

    • Stock Information

  • OncoMaster

  • KR
  • EN
CONTACT US
  • Main
  • News/IR
  • Press Releases

Press Releases

181 Posts
  • 헬로디디

    암 환자 진료만 1만명, 현직 의사 'AI 신약벤처'로 도전장

    11-19-2020
  • 더벨

    AI 신약벤처 온코크로스, 기술특례 IPO 추진

    09-15-2020
  • Dealstreet Asia

    South Korean AI-based pharma firm Oncocross secures $14m Series B

    09-11-2020
  • AVCJ

    Korean AI drug developer secures $14m Series B

    09-10-2020
  • 더벨

    'AI신약연구' 온코크로스, VC업고 '제약 협업' 선도

    09-09-2020
  • Sina

    韩国AI新药企业Oncocross完成约1400万美元B轮融资

    09-08-2020
  • 매일경제

    `AI 신약벤처` 온코크로스, 165억 유치 성공

    09-07-2020
  • Merger Market

    Oncocross welcomes pre-IPO investors for AI drug development; mandates NH I&S for KOSDAQ listing

    09-04-2020
  • 바이오스펙테이터

    온코크로스, 시리즈B 165억.."AI 플랫폼 신약 개발"

    09-04-2020
  • 중앙일보

    온코크로스, AI 신약개발 플랫폼으로 165억 투자 유치

    09-04-2020
  • 조선비즈

    AI 신약 벤처 온코크로스, 165억원 투자 유치

    09-03-2020
  • 더벨

    'AI기반 신약 연구' 온코크로스, 165억 시리즈B 유치

    09-03-2020
  • «
  • ‹
  • 11
  • 12
  • 13
  • 14
  • 15
  • ›
  • »

Please enter a prompt

ONCOCROSS
CEO
Yi Rang KIM / Jihoon KANG
Address
Room 905, 7 Beobwon-ro 11-gil, Songpa-gu, Seoul, Korea (Munjeong-dong, Munjeong Hyundai Knowledge Industry Center 1-2)
Tel
02-717-9967
Fax
02-867-9968
Email
oncocross@oncocross.com
Terms & Conditions Privacy Policy Cookie Policy
ⓒ ONCOCROSS CO., LTD. All Rights Reserved.